SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Submits US and European Regulatory Applications for use of PROMACTA/REVOLADE to Increase Platelet Counts in Patients with Hepatitis C